Stockreport

Trevi Therapeutics to Participate in Upcoming April Events [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC), today [Read more]